The Global Cardiac Amyloidosis Market is estimated to be valued at USD 6.12 Bn in 2024 and is expected to reach USD 11.45 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031. https://hallbook.com.br/blogs/440655/Cardiac-Amyloidosis-Market-Poised-to-Witness-Significant-Growth-due-to